Risk Factors for Invasive Methicillin-Resistant Staphylococcus aureus Infection After Recent Discharge From an Acute-Care Hospitalization, 2011-2013

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Lauren EpsteinFernanda C Lessa

Abstract

Significant progress has been made in reducing methicillin-resistant Staphylococcus aureus (MRSA) infections among hospitalized patients. However, the decreases in invasive MRSA infections among recently discharged patients have been less substantial. To inform prevention strategies, we assessed risk factors for invasive MRSA infection after acute-care hospitalizations. We conducted a prospective, matched case-control study. A case was defined as MRSA cultured from a normally sterile body site in a patient discharged from a hospital within the prior 12 weeks. Eligible case patients were identified from 15 hospitals across 6 US states. For each case patient, 2 controls were matched for hospital, month of discharge, and age group. Medical record reviews and telephone interviews were performed. Conditional logistic regression was used to identify independent risk factors for postdischarge invasive MRSA. From 1 February 2011 through 31 March 2013, 194 case patients and 388 matched controls were enrolled. The median time between hospital discharge and positive culture was 23 days (range, 1-83 days). Factors independently associated with postdischarge MRSA infection included MRSA colonization (matched odds ratio [mOR], 7.71; 95% conf...Continue Reading

References

Dec 1, 1994·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·M D SanfordR P Wenzel
Jan 8, 2003·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·John M BoyceUNKNOWN Healthcare Infection Control Practices Advisory Committee. Society for Healthcare Epidemiology of America. Association for P
Jan 23, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Susan S Huang, Richard Platt
Aug 12, 2005·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Menno R VriensAnnet Troelstra
Jan 6, 2007·The Journal of Infectious Diseases·Susan S HuangUNKNOWN Centers for Disease Control and Prevention Epicenters Program
Oct 18, 2007·JAMA : the Journal of the American Medical Association·R Monina KlevensUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators
Mar 13, 2008·JAMA : the Journal of the American Medical Association·Stephan HarbarthDidier Pittet
Mar 19, 2008·Annals of Internal Medicine·Ari RobicsekLance R Peterson
Feb 20, 2009·JAMA : the Journal of the American Medical Association·Deron C BurtonScott K Fridkin
Jan 15, 2010·Journal of the American Geriatrics Society·Cecilia Big, Preeti N Malani
Feb 27, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Gregory A FiliceRuth Lynfield
Aug 12, 2010·JAMA : the Journal of the American Medical Association·Alexander J KallenUNKNOWN Active Bacterial Core surveillance (ABCs) MRSA Investigators of the Emerging Infections Program
Nov 23, 2010·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Courtney ReynoldsSusan S Huang
Apr 15, 2011·The New England Journal of Medicine·Rajiv JainGary A Roselle
Jan 9, 2013·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Bruce Y LeeSusan S Huang
Feb 12, 2013·American Journal of Infection Control·Jonathan DuffyFernanda C Lessa
Apr 17, 2013·JAMA Internal Medicine·Lona ModySusan S Huang
May 31, 2013·The New England Journal of Medicine·Susan S HuangUNKNOWN AHRQ DECIDE Network and Healthcare-Associated Infections Program
Aug 22, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Duc B NguyenUNKNOWN Active Bacterial Core Surveillance (ABCs) MRSA Investigators of the Emerging Infections Program
Sep 18, 2013·JAMA Internal Medicine·Raymund DantesUNKNOWN Emerging Infections Program–Active Bacterial Core Surveillance MRSA Surveillance Investigators
Apr 26, 2014·Diabetic Foot & Ankle·Lawrence A LaveryNathan A Hunt
Jun 11, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David P CalfeeDeborah S Yokoe
Nov 8, 2014·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·David P CalfeeDeborah S Yokoe

❮ Previous
Next ❯

Citations

Aug 11, 2018·Journal of the American Geriatrics Society·Cheri GriggIsaac See
Jun 1, 2018·Nature Reviews. Disease Primers·Andie S LeeStephan Harbarth
Oct 18, 2019·Expert Opinion on Pharmacotherapy·Matteo BassettiMaddalena Peghin
Jan 11, 2019·Antimicrobial Resistance and Infection Control·David A MonteroRoberto M Vidal
Oct 28, 2019·Environmental Science and Pollution Research International·Anna KozajdaAgnieszka Kapsa
Feb 18, 2016·Current Opinion in Infectious Diseases·Brandon J WebbNathan C Dean
Sep 12, 2017·International Journal of Clinical Practice·Nicholas D BarwellUNKNOWN Scottish Diabetes Foot Action Group
Aug 15, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Richard E NelsonMichael A Rubin
Jun 13, 2018·BMC Infectious Diseases·Guillaume Butler-LaporteTodd C Lee
Oct 21, 2020·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·Alison D LydeckerMary-Claire Roghmann

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR & Staphylococcus

CRISPR-Cas system enables the editing of genes to create or correct mutations. Staphylococci are associated with life-threatening infections in hospitals, as well as the community. Here is the latest research on how CRISPR-Cas system can be used for treatment of Staphylococcal infections.